<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="editorial"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11679982</article-id><article-id pub-id-type="doi">10.3390/ijms252413367</article-id><article-id pub-id-type="publisher-id">ijms-25-13367</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Special Issue: The Role of Extracellular Matrix Proteins in Pathogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5193-4688</contrib-id><name><surname>Cappellano</surname><given-names>Giuseppe</given-names></name><xref rid="af1-ijms-25-13367" ref-type="aff">1</xref><xref rid="af2-ijms-25-13367" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4349-1087</contrib-id><name><surname>Chiocchetti</surname><given-names>Annalisa</given-names></name><xref rid="af1-ijms-25-13367" ref-type="aff">1</xref><xref rid="af2-ijms-25-13367" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3327-6305</contrib-id><name><surname>Raineri</surname><given-names>Davide</given-names></name><xref rid="af1-ijms-25-13367" ref-type="aff">1</xref><xref rid="af2-ijms-25-13367" ref-type="aff">2</xref><xref rid="c1-ijms-25-13367" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-25-13367"><label>1</label>Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Eastern Piedmont, 28100 Novara, Italy; <email>giuseppe.cappellano@med.uniupo.it</email> (G.C.); <email>annalisa.chiocchetti@med.uniupo.it</email> (A.C.)</aff><aff id="af2-ijms-25-13367"><label>2</label>Center for Translational Research on Autoimmune and Allergic Diseases, University of Eastern Piedmont, 28100 Novara, Italy</aff><author-notes><corresp id="c1-ijms-25-13367"><label>*</label>Correspondence: <email>davide.raineri@uniupo.it</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>25</volume><issue>24</issue><elocation-id>13367</elocation-id><history><date date-type="received"><day>03</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>10</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><p>The extracellular matrix (ECM) serves as a complex network that regulates cellular behavior and maintains tissue architecture [<xref rid="B1-ijms-25-13367" ref-type="bibr">1</xref>]. The ECM comprises several structural glycoproteins (collagens, proteoglycans/glycosaminoglycans, elastin, fibronectin, and laminins), as well as metalloproteinases (MMPs) and their inhibitors (TIMPs), which are involved in ECM remodeling. All these components, beyond providing structural support, play critical roles in cellular signaling and immune responses, impacting several physiological and pathological processes such as inflammation, fibrosis, tumor progression, and cardiovascular pathology. ECM proteins are increasingly being recognized as crucial players in the pathogenesis of several human diseases due to their roles in mechanical stability, cell signaling, and immune response modulation.</p><p>In this Special Issue, encompassing five original research articles and three reviews, we bring together diverse studies that explore the multifaceted contributions of ECM proteins to disease mechanisms, shedding light on their potential use as diagnostic biomarkers and therapeutic targets.</p><p>Mohamedi et al. investigated the protective functions of two ECM proteins, namely fibulin-2 and A disintegrin, and metalloproteinase with thrombospondin domains (ADAMTS-12) in lung inflammation and tumorigenesis. By generating a murine model double knockout for fibilin-2 and ADAMTS-12 genes, the authors found an exacerbated inflammatory response and an increased susceptibility to the development of lung tumors, highlighting their potential as therapeutic targets for mitigating inflammatory lung conditions and tumorigenesis [<xref rid="B2-ijms-25-13367" ref-type="bibr">2</xref>].</p><p>Hulahan et al. investigated the impact of ECM alterations in the transition from ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) by using multiplexed spatial proteomics. Through this innovative approach, the study revealed distinct ECM profiles associated with DCIS and IBC; the authors identified specific collagen peptides that could discriminate between DICIS and IBC with a high specificity. The value of this study lies in its demonstration of how ECM profiling can enhance cancer diagnostics and monitoring, particularly by shedding light on the progression from DCIS to IBC and the role of the ECM in tumor invasion [<xref rid="B3-ijms-25-13367" ref-type="bibr">3</xref>].</p><p>The effects of ECM modifications on mesenchymal stem cell (MSC) functions were shown by Komsa-Penkova et al. Among ECM proteins, collagen is essential for tissue repair and becomes structurally compromised through glycation, especially in conditions like diabetes and aging [<xref rid="B4-ijms-25-13367" ref-type="bibr">4</xref>,<xref rid="B5-ijms-25-13367" ref-type="bibr">5</xref>]. This study shows that glycated collagen can significantly alter MSC behavior, reducing cell spreading, adhesion, and cytoskeletal organization. These findings would suggest that non-enzymatic collagen modifications may impair MSC-based repair processes, highlighting the broader implications of ECM modifications in diseases marked by tissue degeneration [<xref rid="B6-ijms-25-13367" ref-type="bibr">6</xref>].</p><p>In addition to structural molecules, the ECM also includes MMPs and their inhibitors, which are known as tissue inhibitors of metalloproteinases (TIMPs) [<xref rid="B7-ijms-25-13367" ref-type="bibr">7</xref>]. MMPs are enzymes that are responsible for breaking down ECM components like collagen and elastin, playing a key role in tissue remodeling and repair. MMP activity is regulated by TIMPs in order to maintain ECM homeostasis [<xref rid="B7-ijms-25-13367" ref-type="bibr">7</xref>].</p><p>In a rat model, Sur&#x000f3;wka et al. showed that long-term immunosuppressive treatments, usually used in transplanted subjects, may disrupt the balance between MMPs and their inhibitors (i.e., TIMPs), leading to structural abnormalities in cardiac tissue, such as collagen accumulation and cardiomyocyte hypertrophy. This study highlights the potential cardiovascular risks of chronic immunosuppression and the need to develop treatment regimens that maintain ECM balance to protect cardiac function in transplant patients [<xref rid="B8-ijms-25-13367" ref-type="bibr">8</xref>].</p><p>A review of the literature on the potential of MMPs and TIMPs serving as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC) is provided by Fornieles et al., with a particular focus on their response to radiotherapy. Metastasis is a major challenge in HNSCC, and understanding how radiotherapy affects MMP and TIMP expression could aid in predicting patient outcomes. This review suggests the need for further research on MMPs and TIMPs as prognostic biomarkers, which could lead to more effective, personalized treatment strategies in managing HNSCC [<xref rid="B9-ijms-25-13367" ref-type="bibr">9</xref>].</p><p>The role of proteoglycans in atherosclerosis and their effect on platelet function was investigated by Drysdale et al. The authors reported that proteoglycans were associated with different atherosclerotic plaque phenotypes. Biglycan and decorin were linked to ruptured plaques, while versican and hyaluronan were more prevalent in eroded ones. These findings suggest that these ECM components may inhibit thrombus formation and could serve as potential targets for developing plaque-specific anti-thrombotic therapies, highlighting the ECM&#x02019;s critical role in regulating vascular pathology [<xref rid="B10-ijms-25-13367" ref-type="bibr">10</xref>].</p><p>Moore et al. explored the impact of genetic factors on ECM integrity and their role in cardiovascular health. Traditionally associated with brittle cornea syndrome, mutations in Zinc finger protein 469 (ZNF469) and PR/SET Domain 5 (PRDM5) genes have recently been implicated in vascular diseases such as aneurysms and dissections [<xref rid="B11-ijms-25-13367" ref-type="bibr">11</xref>]. By describing the effects of ZNF469 and PRDM5 mutations on ECM proteins like collagen, thrombospondin, and transforming growth factor beta 1 (TGF-&#x003b2;1), this study offers a novel perspective on the genetic regulation of ECM components, opening new avenues for understanding and potentially treating cardiovascular disorders [<xref rid="B12-ijms-25-13367" ref-type="bibr">12</xref>].</p><p>Lastly, Chiu et al. elucidated recent findings on the molecular basis of the excessive proliferation and ECM production by orbital fibroblasts and the involvement of certain signaling pathways, leading to tissue expansion/remodeling and fibrosis in Graves&#x02019; ophthalmopathy [<xref rid="B13-ijms-25-13367" ref-type="bibr">13</xref>]. The authors suggest that broadening the concepts of the ECM and tissue fibrosis will help in the development of new therapeutic targets, including multiple antioxidants and antifibrotic agents.</p><p>In conclusion, these studies underscore the pivotal role of ECM proteins in the pathogenesis of a wide array of diseases. Future research aimed at unraveling the complex interactions within the ECM will not only deepen our understanding of disease mechanisms, but also reveal novel therapeutic targets. By developing treatments that specifically modulate ECM proteins and pathways, we can make significant strides in mitigating disease progression, improving diagnostics, and enhancing patient outcomes across various medical fields.</p></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>G.C. wrote and reviewed the manuscript; A.C. reviewed the manuscript; and D.R. conceived the idea and wrote and reviewed the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-25-13367"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frantz</surname><given-names>C.</given-names></name>
<name><surname>Stewart</surname><given-names>K.M.</given-names></name>
<name><surname>Weaver</surname><given-names>V.M.</given-names></name>
</person-group><article-title>The extracellular matrix at a glance</article-title><source>J. Cell Sci.</source><year>2010</year><volume>123</volume><fpage>4195</fpage><lpage>4200</lpage><pub-id pub-id-type="doi">10.1242/jcs.023820</pub-id><pub-id pub-id-type="pmid">21123617</pub-id>
</element-citation></ref><ref id="B2-ijms-25-13367"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohamedi</surname><given-names>Y.</given-names></name>
<name><surname>Fontanil</surname><given-names>T.</given-names></name>
<name><surname>Vega</surname><given-names>J.A.</given-names></name>
<name><surname>Cobo</surname><given-names>T.</given-names></name>
<name><surname>Cal</surname><given-names>S.</given-names></name>
<name><surname>Obaya</surname><given-names>&#x000c1;.J.</given-names></name>
</person-group><article-title>Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>2024</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25042024</pub-id><pub-id pub-id-type="pmid">38396702</pub-id>
</element-citation></ref><ref id="B3-ijms-25-13367"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hulahan</surname><given-names>T.S.</given-names></name>
<name><surname>Spruill</surname><given-names>L.</given-names></name>
<name><surname>Wallace</surname><given-names>E.N.</given-names></name>
<name><surname>Park</surname><given-names>Y.</given-names></name>
<name><surname>West</surname><given-names>R.B.</given-names></name>
<name><surname>Marks</surname><given-names>J.R.</given-names></name>
<name><surname>Hwang</surname><given-names>E.S.</given-names></name>
<name><surname>Drake</surname><given-names>R.R.</given-names></name>
<name><surname>Angel</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Extracellular Microenvironment Alterations in Ductal Carcinoma In Situ and Invasive Breast Cancer Pathologies by Multiplexed Spatial Proteomics</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>6748</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25126748</pub-id><pub-id pub-id-type="pmid">38928454</pub-id>
</element-citation></ref><ref id="B4-ijms-25-13367"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McKay</surname><given-names>T.B.</given-names></name>
<name><surname>Priyadarsini</surname><given-names>S.</given-names></name>
<name><surname>Karamichos</surname><given-names>D.</given-names></name>
</person-group><article-title>Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>1239</elocation-id><pub-id pub-id-type="doi">10.3390/cells8101239</pub-id><pub-id pub-id-type="pmid">31614631</pub-id>
</element-citation></ref><ref id="B5-ijms-25-13367"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pageon</surname><given-names>H.</given-names></name>
<name><surname>Zucchi</surname><given-names>H.</given-names></name>
<name><surname>Rousset</surname><given-names>F.</given-names></name>
<name><surname>Monnier</surname><given-names>V.M.</given-names></name>
<name><surname>Asselineau</surname><given-names>D.</given-names></name>
</person-group><article-title>Skin aging by glycation: Lessons from the reconstructed skin model</article-title><source>Clin. Chem. Lab. Med.</source><year>2014</year><volume>52</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1515/cclm-2013-0091</pub-id><pub-id pub-id-type="pmid">23770560</pub-id>
</element-citation></ref><ref id="B6-ijms-25-13367"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Komsa-Penkova</surname><given-names>R.</given-names></name>
<name><surname>Dimitrov</surname><given-names>B.</given-names></name>
<name><surname>Todinova</surname><given-names>S.</given-names></name>
<name><surname>Ivanova</surname><given-names>V.</given-names></name>
<name><surname>Stoycheva</surname><given-names>S.</given-names></name>
<name><surname>Temnishki</surname><given-names>P.</given-names></name>
<name><surname>Georgieva</surname><given-names>G.</given-names></name>
<name><surname>Tonchev</surname><given-names>P.</given-names></name>
<name><surname>Iliev</surname><given-names>M.</given-names></name>
<name><surname>Altankov</surname><given-names>G.</given-names></name>
</person-group><article-title>Early Stages of Ex Vivo Collagen Glycation Disrupt the Cellular Interaction and Its Remodeling by Mesenchymal Stem Cells-Morphological and Biochemical Evidence</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>5795</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25115795</pub-id><pub-id pub-id-type="pmid">38891981</pub-id>
</element-citation></ref><ref id="B7-ijms-25-13367"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Visse</surname><given-names>R.</given-names></name>
<name><surname>Nagase</surname><given-names>H.</given-names></name>
</person-group><article-title>Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry</article-title><source>Circ. Res.</source><year>2003</year><volume>92</volume><fpage>827</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000070112.80711.3D</pub-id><pub-id pub-id-type="pmid">12730128</pub-id>
</element-citation></ref><ref id="B8-ijms-25-13367"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sur&#x000f3;wka</surname><given-names>A.</given-names></name>
<name><surname>&#x0017b;o&#x00142;nierczuk</surname><given-names>M.</given-names></name>
<name><surname>Prowans</surname><given-names>P.</given-names></name>
<name><surname>Grabowska</surname><given-names>M.</given-names></name>
<name><surname>Kupnicka</surname><given-names>P.</given-names></name>
<name><surname>Markowska</surname><given-names>M.</given-names></name>
<name><surname>Olejnik-Wojciechowska</surname><given-names>J.</given-names></name>
<name><surname>Szlosser</surname><given-names>Z.</given-names></name>
<name><surname>Wilk</surname><given-names>A.</given-names></name>
<name><surname>Szumilas</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>4468</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25084468</pub-id><pub-id pub-id-type="pmid">38674053</pub-id>
</element-citation></ref><ref id="B9-ijms-25-13367"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fornieles</surname><given-names>G.</given-names></name>
<name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>M.I.</given-names></name>
<name><surname>Exp&#x000f3;sito</surname><given-names>J.</given-names></name>
</person-group><article-title>Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>25</volume><elocation-id>527</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25010527</pub-id><pub-id pub-id-type="pmid">38203696</pub-id>
</element-citation></ref><ref id="B10-ijms-25-13367"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Drysdale</surname><given-names>A.</given-names></name>
<name><surname>Blanco-Lopez</surname><given-names>M.</given-names></name>
<name><surname>White</surname><given-names>S.J.</given-names></name>
<name><surname>Unsworth</surname><given-names>A.J.</given-names></name>
<name><surname>Jones</surname><given-names>S.</given-names></name>
</person-group><article-title>Differential Proteoglycan Expression in Atherosclerosis Alters Platelet Adhesion and Activation</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>950</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25020950</pub-id><pub-id pub-id-type="pmid">38256024</pub-id>
</element-citation></ref><ref id="B11-ijms-25-13367"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>P.</given-names></name>
<name><surname>Wolf</surname><given-names>A.</given-names></name>
<name><surname>Sathyamoorthy</surname><given-names>M.</given-names></name>
</person-group><article-title>The Association of Novel Single-Nucleotide Variants in the Collagen Matrix-Encoding Gene PRDM5 with Aortic Aneurysmal Disease</article-title><source>Life</source><year>2023</year><volume>13</volume><elocation-id>1649</elocation-id><pub-id pub-id-type="doi">10.3390/life13081649</pub-id><pub-id pub-id-type="pmid">37629506</pub-id>
</element-citation></ref><ref id="B12-ijms-25-13367"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moore</surname><given-names>P.</given-names></name>
<name><surname>Wolf</surname><given-names>A.</given-names></name>
<name><surname>Sathyamoorthy</surname><given-names>M.</given-names></name>
</person-group><article-title>An Eye into the Aorta: The Role of Extracellular Matrix Regulatory Genes ZNF469 and PRDM5, from Their Previous Association with Brittle Cornea Syndrome to Their Novel Association with Aortic and Arterial Aneurysmal Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>5848</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25115848</pub-id><pub-id pub-id-type="pmid">38892036</pub-id>
</element-citation></ref><ref id="B13-ijms-25-13367"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiu</surname><given-names>H.I.</given-names></name>
<name><surname>Wu</surname><given-names>S.B.</given-names></name>
<name><surname>Tsai</surname><given-names>C.C.</given-names></name>
</person-group><article-title>The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves&#x02019; Ophthalmopathy</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>3288</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25063288</pub-id><pub-id pub-id-type="pmid">38542262</pub-id>
</element-citation></ref></ref-list></back></article>